| Title |
Recent advances of chitosan nanoparticles as drug carriers
|
|---|---|
| Published in |
International Journal of Nanomedicine, April 2011
|
| DOI | 10.2147/ijn.s17296 |
| Pubmed ID | |
| Authors |
Jun Jie Wang, Zhao Wu Zeng, Ren Zhong Xiao, Tian Xie, Guang Lin Zhou, Xiao Ri Zhan, Shu Ling Wang |
| Abstract |
Chitosan nanoparticles are good drug carriers because of their good biocompatibility and biodegradability, and can be readily modified. As a new drug delivery system, they have attracted increasing attention for their wide applications in, for example, loading protein drugs, gene drugs, and anticancer chemical drugs, and via various routes of administration including oral, nasal, intravenous, and ocular. This paper reviews published research on chitosan nanoparticles, including its preparation methods, characteristics, modification, in vivo metabolic processes, and applications. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 833 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 2 | <1% |
| Iran, Islamic Republic of | 2 | <1% |
| Turkey | 1 | <1% |
| Malaysia | 1 | <1% |
| Portugal | 1 | <1% |
| Pakistan | 1 | <1% |
| Ireland | 1 | <1% |
| South Africa | 1 | <1% |
| Switzerland | 1 | <1% |
| Other | 4 | <1% |
| Unknown | 818 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 172 | 21% |
| Student > Master | 152 | 18% |
| Student > Bachelor | 91 | 11% |
| Researcher | 76 | 9% |
| Student > Doctoral Student | 38 | 5% |
| Other | 120 | 14% |
| Unknown | 184 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 109 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 104 | 12% |
| Chemistry | 100 | 12% |
| Biochemistry, Genetics and Molecular Biology | 70 | 8% |
| Medicine and Dentistry | 60 | 7% |
| Other | 170 | 20% |
| Unknown | 220 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2021.
All research outputs
#7,355,485
of 25,373,627 outputs
Outputs from International Journal of Nanomedicine
#814
of 4,123 outputs
Outputs of similar age
#39,112
of 120,712 outputs
Outputs of similar age from International Journal of Nanomedicine
#9
of 33 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 4,123 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,712 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.